Akanda Corp.
NASDAQAKAN SI utilization hits 91.96%, near the 52-week high of 100%. The Nasdaq-listed pharmaceutical stock has seen short interest surge 888%…
Short interest % of float, cost to borrow, utilization, and put/call ratio for AKAN are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Akanda Corp. heads into its May 7 earnings print as one of the most compressed and turbulent small-cap set-ups on Nasdaq — a stock up more than 1,200% in a month, now absorbing a short-seller attack, with the borrow…
Akanda Corp. arrives at its April 30 earnings print riding one of the most explosive short-squeeze setups seen in the small-cap cannabis space this year. The lending market tells the loudest story heading into the…
Snapshot as of 6 May 2026
Why this matters — Three distinct ORTEX data streams converged on AKAN (Akanda Corp.) simultaneously: short interest, cost to borrow, and utilisation all hit extreme readings within the same 24-hour window. The stock…
Why this matters — Three distinct ORTEX short-squeeze data points have aligned on AKAN within 24 hours. Short interest, cost to borrow, and utilisation all surged simultaneously, marking one of the sharpest stress…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AKAN — free to start on ORTEX.
Sign up for free →Open AKAN on ORTEX